GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » DOD Biotech PCL (BKK:DOD) » Definitions » Asset Impairment Charge

DOD Biotech PCL (BKK:DOD) Asset Impairment Charge : ฿147.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is DOD Biotech PCL Asset Impairment Charge?

DOD Biotech PCL's Asset Impairment Charge for the three months ended in Mar. 2025 was ฿-5.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 was ฿147.2 Mil.


DOD Biotech PCL Asset Impairment Charge Historical Data

The historical data trend for DOD Biotech PCL's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DOD Biotech PCL Asset Impairment Charge Chart

DOD Biotech PCL Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.70 188.10 382.89 -12.56 137.80

DOD Biotech PCL Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.34 188.50 -6.92 -29.44 -4.97

DOD Biotech PCL Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿147.2 Mil.


DOD Biotech PCL Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of DOD Biotech PCL's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


DOD Biotech PCL Business Description

Traded in Other Exchanges
Address
No. 111, Moo 2, Tumbol Taa jeen, Amphor Muengsamutsakhon, Samut Sakhon, THA, 74000
DOD Biotech PCL is principally engaged in the manufacture and distribution of food supplements and health drinks of all kinds. The company is organized into business units based on its products and services and has reportable segments as; Supplementary business, Manufacturing cosmetic business, Manufacturing extraction business, and others. A majority of its revenue is generated from the Supplementary business which manufactures and sells dietary supplements in the form of capsules, tablets, soft gels, gummies, probiotics, shot drinks, and others. Geographically, the company operates only in Thailand.

DOD Biotech PCL Headlines

No Headlines